| |
| |
|
| Insider
Information: |
Rapp Michael |
| Relationship: |
Director |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
5,134,370 |
|
|
Indirect Shares
|
1,853,408 |
|
|
| Direct
Value |
$25,229,986 |
|
|
|
Indirect Value
|
$11,089,967 |
|
|
| Total
Shares |
6,987,778 |
|
|
| Total
Value |
$36,319,953 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
7
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
6
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 -54.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ONE Group Hospitality Inc |
STKS |
Director |
2013-10-16 |
1,563,198 |
2013-04-23 |
1,564,199 |
Premium* |
|
|
Lihua International Inc. |
LIWA |
Officer, Director, 10%... |
2007-07-13 |
1,000,000 |
|
0 |
Premium* |
|
|
Zynerba Pharmaceuticals, Inc. |
ZYNE |
10% Owner |
2018-05-30 |
1,500,000 |
2015-08-04 |
80,467 |
Premium* |
|
|
Immunome Inc. |
IMNM |
Director |
2023-10-02 |
1,071,172 |
2023-10-02 |
208,742 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| IMNM |
Immunome Inc. |
Director |
– • – |
2023-10-02 |
4 |
A |
$5.91 |
$1,499,993 |
D/D |
253,806 |
1,071,172 |
0 |
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2023-01-15 |
4 |
A |
$4.00 |
$70,000 |
D/D |
17,500 |
817,366 |
0 |
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2021-09-13 |
4 |
B |
$19.96 |
$518,202 |
I/I |
25,962 |
208,742 |
2.1 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2021-09-10 |
4 |
B |
$17.85 |
$276,675 |
I/I |
15,500 |
182,780 |
2.1 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2021-09-09 |
4 |
B |
$17.44 |
$553,774 |
I/I |
30,450 |
167,280 |
2.1 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2021-05-26 |
4 |
B |
$18.94 |
$43,562 |
I/I |
2,300 |
136,830 |
2.1 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2021-05-25 |
4 |
B |
$18.32 |
$353,631 |
I/I |
19,303 |
134,530 |
2.1 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2021-05-24 |
4 |
B |
$18.38 |
$586,230 |
I/I |
31,895 |
115,227 |
2.1 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2020-10-06 |
4 |
A |
$0.00 |
$0 |
D/D |
555,554 |
555,554 |
0 |
- |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2020-10-06 |
4 |
B |
$12.00 |
$999,984 |
D/D |
83,332 |
638,886 |
2.39 |
% |
|
| IMNM |
Immunome Inc. |
Director |
– • – |
2020-10-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
827,640 |
|
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2018-05-30 |
4 |
B |
$10.45 |
$61,498 |
D/D |
5,885 |
1,500,000 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2018-05-02 |
4 |
B |
$10.46 |
$156,945 |
D/D |
15,000 |
1,494,115 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2018-03-22 |
4 |
B |
$9.28 |
$92,790 |
D/D |
10,000 |
1,479,115 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2018-01-02 |
4 |
B |
$12.99 |
$194,847 |
D/D |
15,000 |
1,469,115 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2017-10-23 |
4 |
B |
$9.94 |
$255,795 |
D/D |
25,745 |
1,454,115 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2017-10-20 |
4 |
B |
$9.78 |
$293,538 |
D/D |
30,000 |
1,428,370 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2017-10-19 |
4 |
B |
$9.59 |
$424,405 |
D/D |
44,255 |
1,398,370 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2016-12-29 |
4 |
B |
$15.85 |
$158,500 |
D/D |
10,000 |
1,354,115 |
2.45 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2016-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
80,467 |
1,344,115 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2015-08-10 |
4 |
A |
$0.00 |
$0 |
D/D |
567,505 |
1,263,648 |
0 |
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2015-08-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
80,467 |
|
- |
|
| ZYNE |
Zynerba Pharmaceuticals, ... |
10% Owner |
– – • |
2015-08-04 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
696,143 |
|
- |
|
| STKS |
ONE Group Hospitality Inc |
Director |
– • – |
2013-10-16 |
4 |
B |
$5.00 |
$815,280 |
D/D |
163,056 |
1,563,198 |
2.39 |
- |
|
| STKS |
ONE Group Hospitality Inc |
President and Chairman |
• • – |
2013-04-23 |
4 |
D |
$0.00 |
$0 |
I/I |
(121,500) |
1,564,199 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
